PAS
IMCR icon

Point72 Asia (Singapore)’s Immunocore IMCR Stock Holding History

Point72 Asia (Singapore)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$150K Buy
+4,121
New +$140K 0.02% 363

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Point72 Asia (Singapore)'s IMCR Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Immunocore (IMCR) in Q3 2025: 4,121 shares worth $150K. The stake represents 0.02% of the portfolio and ranks #363 among its holdings.

132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • Point72 Asia (Singapore) held 4,121 shares of Immunocore worth $150K as of Q3 2025.
  • Immunocore was a new Point72 Asia (Singapore) position in Q3 2025.
  • Immunocore made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #363 holding.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.